HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad Reza Zarrindast Selected Research

Sulpiride (neogama)

1/2021Anodal tDCS applied to the left frontal cortex abrogates scopolamine‑induced fear memory deficit via the dopaminergic system.
6/2013Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.
5/2010Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice.
3/2008Morphine sex-dependently induced place conditioning in adult Wistar rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad Reza Zarrindast Research Topics

Disease

21Amnesia (Dissociative Amnesia)
06/2013 - 09/2002
7Memory Disorders (Memory Loss)
01/2021 - 03/2003
4Cholestasis
01/2014 - 11/2011
2Tremor (Tremors)
01/2021 - 05/2010
2Opioid-Related Disorders (Opiate Addiction)
12/2019 - 10/2016
2Substance-Related Disorders (Drug Abuse)
06/2018 - 10/2015
2Inflammation (Inflammations)
01/2017 - 02/2010
2Postpartum Depression (Post-Natal Depression)
05/2012 - 01/2010
1Hearing Loss (Hearing Impairment)
02/2018
1Morphine Dependence
05/2017
1Encephalitis (Encephalitis, Rasmussen)
01/2017
1Ischemic Stroke
07/2016
1Hypoxia (Hypoxemia)
07/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2016
1Hepatic Encephalopathy
06/2013
1Muscle Cramp (Cramp)
01/2013
1Sleep Wake Disorders
01/2013
1Pheochromocytoma
07/2012
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
03/2012
1Brain Ischemia (Cerebral Ischemia)
01/2012
1Ischemia
01/2012
1Hallucinations (Hallucination)
05/2010
1Carcinoma (Carcinomatosis)
03/2010
1Pain (Aches)
02/2010
1Major Depressive Disorder (Major Depressive Disorders)
01/2010
1Nervous System Diseases (Neurological Disorders)
01/2010
1Malnutrition (Nutritional Deficiencies)
01/2010

Drug/Important Bio-Agent (IBA)

7Morphine (MS Contin)FDA LinkGeneric
07/2012 - 09/2002
7Pharmaceutical PreparationsIBA
04/2012 - 01/2008
6Scopolamine (Hyoscine)FDA Link
01/2021 - 07/2010
6N-Methylaspartate (NMDA)IBA
07/2012 - 12/2010
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2011 - 07/2007
4Sulpiride (neogama)IBA
01/2021 - 03/2008
4SCH 23390IBA
01/2021 - 05/2010
4CannabinoidsIBA
03/2017 - 04/2008
4Naloxone (Narcan)FDA LinkGeneric
06/2013 - 03/2008
4Opioid Analgesics (Opioids)IBA
06/2013 - 03/2008
3Neurotransmitter Agents (Neurotransmitter)IBA
05/2017 - 01/2010
3CB1 Cannabinoid Receptor (CB1 Receptor)IBA
03/2017 - 10/2009
3Dopamine Receptors (Dopamine Receptor)IBA
10/2015 - 05/2010
3harman (harmane)IBA
01/2013 - 05/2010
3Cholinergic Agents (Cholinergics)IBA
08/2012 - 07/2010
3NicotineFDA Link
03/2012 - 07/2007
2Anti-Anxiety Agents (Anxiolytics)IBA
01/2021 - 11/2011
2Biomarkers (Surrogate Marker)IBA
12/2019 - 10/2016
2Messenger RNA (mRNA)IBA
06/2018 - 10/2016
2LipopolysaccharidesIBA
01/2017 - 07/2012
2Dopamine (Intropin)FDA LinkGeneric
06/2013 - 05/2010
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2013 - 03/2012
2Tuberculin (PPD)IBA
05/2012 - 01/2010
2ApomorphineFDA Link
05/2010 - 10/2009
2Histamine (Histamine Dihydrochloride)FDA Link
05/2010 - 01/2008
2Adrenergic Receptors (Adrenergic Receptor)IBA
03/2003 - 10/2002
1Dopamine AntagonistsIBA
01/2021
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
12/2019
1Dynorphins (Dynorphin)IBA
12/2019
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
12/2019
1Methadone (Dolophine)FDA LinkGeneric
12/2019
1Nerve Growth Factors (Neurotrophins)IBA
02/2018
15-HT1 Serotonin ReceptorsIBA
03/2017
1Pentoxifylline (Trental)FDA LinkGeneric
01/2017
1Interleukin-10 (Interleukin 10)IBA
01/2017
1Interferon-gamma (Interferon, gamma)IBA
01/2017
1cocaine- and amphetamine-regulated transcript proteinIBA
10/2016
1Peptides (Polypeptides)IBA
10/2016
1Proteins (Proteins, Gene)FDA Link
10/2016
1Deferoxamine (Desferal)FDA LinkGeneric
07/2016
1mu Opioid Receptors (mu Opioid Receptor)IBA
06/2013
1Arginine (L-Arginine)FDA Link
01/2013
1BenzodiazepinesIBA
01/2013
1Dopamine Agents (Dopaminergic Agents)IBA
10/2012
1Opioid Receptors (Opioid Receptor)IBA
10/2012
12-amino-7-phosphonoheptanoic acidIBA
05/2012
1Thiamine (Aneurin)FDA Link
05/2012
12,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA
04/2012
1Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
04/2012
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
04/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2012
1MecamylamineIBA
03/2012
1Nitric Oxide Synthase (NO Synthase)IBA
03/2012
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2012
1Tacrolimus (Prograf)FDA LinkGeneric
01/2012
1Bile Acids and Salts (Bile Acids)IBA
11/2011
1CholesterolIBA
11/2011
1Dizocilpine Maleate (Dizocilpine)IBA
10/2011
1AlkaloidsIBA
05/2010
1Dopamine Agonists (Dopamine Agonist)IBA
05/2010
1Serotonin (5 Hydroxytryptamine)IBA
03/2010
1Formaldehyde (Formol)FDA Link
02/2010
1Trace Elements (Biometals)IBA
01/2010
1MagnesiumIBA
01/2010
1ZincIBA
01/2010
1IronIBA
01/2010
1Hormones (Hormone)IBA
01/2010

Therapy/Procedure

6Injections
01/2013 - 03/2008
4Ligation
01/2014 - 11/2011
1Transcranial Direct Current Stimulation
01/2021
1Cochlear Implantation
02/2018
1Transplantation
07/2016